H.R. 767 · 119th Congress · Health
FLASH Act of 2025
A bill that started in the House. To become law it must pass the House and the Senate in identical form and be signed by the President.
Where it stands
In committee in the House
- Introduced — doneJan 28, 2025
- Committee — not yet
- Passed the House — not yet
- Passed the Senate — not yet
- Sent to the President — not yet
- Became law — not yet
Latest action · Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
What this bill means
In plain English
This bill expands federal contracting and other authorities to support the development and acquisition of products and supplies that are necessary for national public health and health security.
From the official summary by the Congressional Research Service (introduced in house version). The full summary is below.
If it passes
It becomes federal law, and what it describes takes effect on the dates written into the bill.
What still has to happen
- 1A House committee must take it up and approve it. Most bills never get past this step.
- 2Then the full House must pass it.
- 3Then the Senate must pass it in the same form.
- 4Then it goes to the President to sign or veto.
If it doesn't pass
- Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
- This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in House · Jan 28, 2025
This bill expands federal contracting and other authorities to support the development and acquisition of products and supplies that are necessary for national public health and health security.
Specifically, the Department of Health and Human Services (HHS) may use noncompetitive procedures to procure medical countermeasures (e.g., vaccines), chemical materials and reagents, manufacturing supplies, and similar items that are needed to develop products for national public health and health security.
Additionally, HHS may acquire, subject to dollar limits and other conditions, innovative commercial products and services by selecting proposals through a general solicitation and peer review.
Further, the bill expands the activities of the Biomedical Advanced Research and Development Authority (BARDA) to include supporting the design and development of prototypes for products to diagnose, mitigate, prevent, treat, or otherwise respond to biological, chemical, radiological, or nuclear threats, including pandemics or epidemics. If BARDA enters an initial transaction to design or develop such a test or prototype using competitive procedures, BARDA may use noncompetitive procedures for a follow-on transaction to produce the test or prototype.
Who started it
Sponsor — the member who introduced it

Introduced in the House on Jan 28, 2025.
See Robert Garcia's votes and donorsCosponsors — members who signed on in support
No other member has signed on to this measure so far.
Committees handling it
A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.
Energy and Commerce Committee
House
- Referred To · Jan 28, 2025
Full timeline
Every recorded action on H.R. 767, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.
- IntroducedHouse
Introduced in House
- House
Referred to the House Committee on Energy and Commerce.
Have a view on H.R. 767? Your leaders vote on it.
Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.
Write your leaders about thisSource: Congress.gov record for H.R. 767(opens in new tab)